These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7249786)

  • 1. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
    Lingaas E; Midtvedt T; Melby K; Dahl OU
    Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of clinical isolates of bacteria to cefoxitin and cephalothin.
    Moellering RC; Dray M; Kunz LJ
    Antimicrob Agents Chemother; 1974 Sep; 6(3):320-3. PubMed ID: 15830480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of clinical strains of bacteria to cefoxitin.
    Bremner DA
    N Z Med J; 1981 Sep; 94(691):173-4. PubMed ID: 6945507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
    Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
    Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I; Dickert H; Machka K
    Infection; 1979; 7(5):231-6. PubMed ID: 389804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microbiological evaluation of cefoxitin, a new beta-lactamase resistant cephamycin antibiotic, compared to cephalothin, cephaloridine and cefazolin].
    Schassan HH; Bentfeld G
    Fortschr Med; 1978 Aug; 96(30):1510-7. PubMed ID: 669547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoxitin and cephalothin: antimicrobial activity, human pharmacokinetics, and toxicology.
    Brumfitt W; Kosmidis J; Hamilton-Miller JM; Gilchrist JN
    Antimicrob Agents Chemother; 1974 Sep; 6(3):290-9. PubMed ID: 15830475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial evaluation of cefoxitin: a new semisynthetic cephamycin. Comparative studies with cefazolin and cefalotin.
    Une T; Mitsuhashi S
    Arzneimittelforschung; 1977; 27(1):89-93. PubMed ID: 576821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae to cefoxitin and BL-S786.
    Meyer RD
    J Antibiot (Tokyo); 1977 Apr; 30(4):326-9. PubMed ID: 324961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of imipenem against 1386 clinical isolates.
    Belobraydic KA; Qadri SM
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothin.
    Goodwin CS; Raftery EB; Goldberg AD; Skeggs H; Till AE; Martin CM
    Antimicrob Agents Chemother; 1974 Sep; 6(3):338-46. PubMed ID: 15830485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.